QSV Equity Investors’s West Pharmaceutical WST Stock Holding History

QSV Equity Investors’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$280K	Sell	1,018 -49	-5%	-$13.4K	0.41%	75
2025 Q3	$280K	Sell	1,067 -24	-2%	-$5.83K	0.29%	80
2025 Q2	$239K	Hold	1,091	–	–	0.25%	84
2025 Q1	$244K	Sell	1,091 -5	-0.5%	-$1.38K	0.25%	83
2024 Q4	$359K	Buy	1,096 +10	+0.9%	+$3.15K	0.35%	64
2024 Q3	$326K	Buy	1,086 +169	+18%	+$51.8K	0.31%	67
2024 Q2	$302K	Sell	917 -144	-14%	-$50.9K	0.32%	64
2024 Q1	$420K	Hold	1,061	–	–	0.4%	64
2023 Q4	$374K	Buy	+1,061	New	+$375K	0.36%	68

Other funds holding WST

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

GIM

Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

QSV Equity Investors's WST Position: Q4 2025 in Review

QSV Equity Investors reduced its West Pharmaceutical (WST) stake by 4.6% in Q4 2025, selling an estimated $13.4K and leaving 1,018 shares worth $280K. The position accounts for 0.41% of the portfolio, ranked #75.

QSV Equity Investors first reported a position in WST in Q4 2023 and has held it in 9 quarters since. The position peaked at $420K in Q1 2024. 804 funds tracked by Wall St. Rank hold WST as of Q4 2025.

QSV Equity Investors held 1,018 shares of West Pharmaceutical worth $280K as of Q4 2025.
QSV Equity Investors sold 49 West Pharmaceutical shares in Q4 2025, an estimated $13.4K.
West Pharmaceutical made up 0.41% of QSV Equity Investors's portfolio in Q4 2025, its #75 holding.
QSV Equity Investors first reported a position in West Pharmaceutical in Q4 2023 and has held it in 9 quarters since.
QSV Equity Investors's West Pharmaceutical position peaked at $420K in Q1 2024.
804 funds tracked by Wall St. Rank held West Pharmaceutical as of Q4 2025.

Based on QSV Equity Investors's 13F filing for Q4 2025, filed 12 Feb 2026.